Send the following on WhatsApp
Continue to Chathttps://nl.marketscreener.com/koers/aandeel/CSTONE-PHARMACEUTICALS-57946082/nieuws/CStone-Pharmaceuticals-kondigt-goedkeuring-door-NMPA-aan-van-sugemalimab-voor-patienten-met-recidie-45192546/?utm_source=whatsapp&utm_medium=social&utm_campaign=share